In lung cancer treatment, when the PI3K-Akt pathway is inactivated, curcumin (DMC) enhanced the sensitivity of drug-resistant lung cancer cells to cisplatin by downregulating the expression of thymidine phosphorylase and RCC1 [195]. Here, TYMP is linked to lung carcinoma.